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Purpose: The purpose of the current study was to examine the effect of zinc supplementation as a
nutritional supplement in case of osteopenia induced microarchitectural changes in rat model.
Methods: Forty eight animals in two batches of twenty four animals each were assigned to four groups:
Control, Zinc, Ovariectomized (OVX) and OVX þ Zinc. The treatment period was continued for eight
weeks. Histoarchitecture analysis was performed on both the bones i.e. femur and tibia using light as
well as electron microscopy. Also, the bone calcium content was estimated using atomic absorption
spectrophotometer.
Results: The body weight of the animals in the OVX group was signiﬁcantly higher in comparison to the
control animals. The body weight was found to increase signiﬁcantly upon zinc supplementation to OVX
animals till the 4th week and then was almost comparable till the termination of treatment period.
Calcium content in both femur and tibia were found to be signiﬁcantly reduced in the ovariectomized
group. The connectivity of trabeculae was lost following ovariectomy. Zinc administration restored bone
calcium content as well bone tissue morphology including trabecular thickness.
Conclusion: These ﬁndings suggest that changes in the trabecular bone attributed to estrogen deﬁciency
are arrested by zinc supplementation.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Osteoporosis is a skeletal disease characterised by low bone
mass and structural weakening of the bone material that leads to
reduced bone strength [1]. Postmenopausal osteoporosis is by far
the commonest form of age-related bone loss. In women, bone loss
is exacerbated after menopause due to a decrease in estrogen
production. It is estimated that 10 million individuals have osteo-
porosis while another 34 million suffer from low bone density.
Upon survey, it has been found that 61 million individuals will
develop osteoporosis or low bone density by 2020 [2]. Beyond
medical costs, there is the physical burden of living with osteopo-
rosis and its impact on the daily life style, including restrictions in
daily activities, loss of conﬁdence (due to fear of falling and frac-
ture) and loss of independence [3].
The development of osteoporosis is thought to be primarilycs, Panjab University, Basic
waj).
r Inc. This is an open access articlerelated to ageing, genetic factors. Some modiﬁable factors, such as
smoking, excess alcohol consumption, life style and deﬁciency or
excess of some of the components of diet, are also associated with
osteoporosis [4]. Therapies for osteoporosis fall into two categories:
antiresorptive drugs, which slow bone resorption, and anabolic
drugs, which stimulate bone formation. However, the adverse ef-
fects of these medications include malignant tumour formation
with hormone therapy and gastrointestinal tolerance problems
with bisphosphonates, which may exclude their long-term use
[5,6]. Thus, there is a need for some alternative that can improve
bone health without inducing adverse effects. Growing evidence of
the beneﬁts of natural foods for bone health presents alternatives
for the prevention or treatment of osteoporosis [7,8]. Trace ele-
ments play amajor role in the growth and development of skeleton,
of which zinc is of particular interest to us.
The fact that the organic component in the bone is mainly
composed of protein and that most of the bone mineral portion is
calcium implies that the essential nutrients required for bone
health are protein and calcium [9]. In addition this, certain min-
erals, vitamins and trace metals are also required for theunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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is an essential trace element, is a component of 200 enzymes and is
also well known to be necessary for normal mineralization and
collagen synthesis in bone. Yamaguchi et al. studied the direct ef-
fects of zinc on the proliferative activity of bone cells and found that
it has a stimulatory effect on osteoblastic bone formation and an
inhibitory effect on osteoclastic bone resorption. Zinc produced
remarkable increases in alkaline phosphatase activity and protein
concentration in osteoblasts [11,12]. The role of zinc has been
studied previous in terms of zinc deﬁciency or adequate zinc diet.
Zn-deﬁcient diets have impairment in growth plate chondrocyte
proliferation, body length gain [13,14] and bone mass [15] in
animals.
However, to the best of our knowledge, little research on the
association between zinc supplementation and bone micro archi-
tecture in the osteopenic condition has been conducted. To address
this issue, the present study investigated the effect of zinc sup-
plementation on bone calcium content and microarcitecture in
osteopenic rat model.2. Material and methods
To carry out the present study, forty eight female Wistar rats (12
weeks old, 100e150g) in a batch of two were procured from the
Central Animal House of Panjab University, Chandigarh. The ani-
mals were housed in polypropylene cages bedded with rice husk.
They were given clean drinking tap water and standard animal
pellet diet (Ashirwad Industries, Kharar, Punjab, India), throughout
the experiment ad libitum. The animals were randomly divided into
four groups comprising twelve animals in each group. They were
acclimatized for oneweek to laboratory conditions prior to the start
of the experimental procedure. Group 1 (Control) was given stan-
dard diet as well as drinking water. Group 2 (Zinc) was given zinc
supplement as zinc sulphate in drinking water at a dose level of
227 mg of ZnSO4.7H2O per litre [16]. Group 3 (OVX) animals were
bilaterally ovariectomized and were kept under normal feeding
conditions without any zinc supplementation. Group 4
(OVX þ Zinc) animals were bilaterally ovariectomized and given
zinc in drinking water (227 mg of ZnSO4.7H2O per litre). The
treatment period was continued for eight weeks. The experimental
design and procedures were approved by the Ethical Committee on
Animal Experiments of the Central Animal House, Panjab Univer-
sity, Chandigarh, India.
It was not possible to carry the measurements in a single batch.
Therefore, measurements of all the parameters were done in two
batches. These batches were segregated in different time over a
period of one year. The ﬁrst batch includes the ash content analysis
and the second batch includes the histological analysis using light
and electron microscopy.2.1. Surgical procedure for bilateral ovariectomy
Ovariectomy was performed in female Wistar rats by the
method as described in our previous paper [17]. The ovariecto-
mized Wistar rat model is the FDA recommended model and has
been widely used for the rapid development of osteoporosis for
purposes of investigating aspects of pathogenesis and treatment of
postmenopausal bone loss [18].
At the completion of termination period, the animals were
sacriﬁced by decapitation under anesthesia (using diethyl ether)
and both the femora and tibiae were extracted. Bones of all the
animals were cleared off from the muscle and cartilage and were
further processed.2.2. Elemental analysis
The method of Szpunar et al. [19] was partially modiﬁed for
bone digestion. Bone specimens were digested in concentrated
nitric acid, and trace element analysis for the bone tissue was
performed using an atomic absorption spectrophotometer (model
3100; PerkinElmer). Calcium hollow cathode lamp was operated at
a slit width of 0.7 nm, which was selected to isolate 422.7 nm lines.
Calcium standard (1000 ppm) was used for calibrating the system.
2.3. Micro architectural analysis
Microscopy was done to analyze themicrostructure of bone that
includes arrangement and geometry of the trabecular region. Also,
the adipocytes present in the bone marrow were analyzed using
light microscopy.
2.3.1. Light microscopy
2.3.1.1. Bone sample preparation
2.3.1.1.1. Bone tissue preparation (ﬁxation and embedding) for
Hematoxylin-eosin staining. After excision, the trabecular regions
(sectioned from the metaphyseal region along the growth plate) of
the femora and tibia of all the groups were sectioned and ﬁxed
immediately in 4% formaldehyde prepared in 0.1M phosphate
buffer (pH 7.2) overnight. After this, all the samples were decal-
ciﬁed in 10% Ethylene Diamine Tetra Acetic acid (EDTA) prepared in
0.05M TriseHCl buffer, pH 7.2. All the samples were removed from
demineralising solution and washed in phosphate buffer saline.
Then they were treated in ﬁve different gradients of alcohol
(starting from 30% ethanol to absolute alcohol) for 1hr. After this
they were dipped in absolute alcohol and benzene (1:1) for half an
hour, only benzene for half an hour and then inwax for 6 h. Samples
were then embedded in the parafﬁn wax (melting temperature
60 C) using plastic cassettes. Plastic cassettes were then inserted
into the microtome so that the wax block faces the blade. The thin
bone tissue sections (of about 4e10 mm thin) were then sliced and
further processed for different staining protocols. HE staining was
done to visualize the diaphyseal cortical bone thickness of both the
femora and the tibia upon ovariectomy and zinc supplementation.
After deparafﬁnising in xylene for about 15 min, the sections were
immersed in the graded alcohol solutions (90% ethanol to 30%
ethanol). After this the slides were dipped in Hematoxylin for
1e2 min. The slides were rinsed under running tap water in
staining box until thewater is no longer coloured (~5min). Sections
were again immersed in eosin stain for 1e2 min and rinsed until
water became clear. Then again the slides were kept in gradient of
ethanol and were shifted to xylene till they were cover slipped.
Then the slides were viewed and analyzed under the light micro-
scope (Leica).
2.3.1.2. Bone marrow preparation. Adipocytes were analyzed by
extracting bone marrow cells from the femur bone. The marrow
cells were then stained with h and e stain as according to the
standard protocol. The stained sections were then analyzed under
light microscope (Leica).
2.3.2. Scanning electron microscopy
2.3.2.1. Bone sample preparation. The bone samples were pro-
cessed for the assessment of microarchitecture as per the method
followed by Chang et al. [20]. Longitudinal section of all the bone
samples (trabecular region sectioned from the metaphyseal growth
plate) were immersed in a tissue ﬁxative solution (4% formalde-
hyde in phosphate buffer saline) for at least one day and then rinsed
with the Phosphate buffer saline (PBS) before characterization. For
SEM, the bone was polished and etched in a hydrogen peroxide
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dehydrated by 10 min immersions in ﬁve different concentrations
(50%e100%) of ethanol solution. The dried bone specimens were
mounted on the aluminium stubs (covered by carbon tape) and
sputter-coated with gold. After this, the endosteal portion
(trabecular region) of the femora and tibiae's microstructures were
examined by scanning electron microscopy (Fine coat Ion sputter
JSM-6100 JEOL) operating at 15 KV in the Sophisticated Analytical
Instrumentation Facility, CIL, Panjab University, Chandigarh, India.
2.4. Statistical analysis
Data are expressed as mean (SD). One-way analysis of variance
was used to evaluate differences among groups. NewmaneKeuls
post hoc test was used for multiple comparisons between groups.
Differences were considered statistically signiﬁcant at P < 0.05. The
statistical analysis software SPSS (version 14) was adopted to pro-
cess the data in the present study.
3. Results
3.1. Dose administered to each animal
Zinc supplementation in the drinking water can be considered
as an appropriate and customary method for supplementing
nutrition. To calculate the dose of elemental zinc taken by an ani-
mal, each animal's daily consumption of drinking water was
recorded which varied between 25 and 30 ml. Taking into consid-
eration the daily consumption of drinking water and the average
body weight of animals, we estimated zinc consumption to vary
between 8 and 9 mg/kg body weight [17].
3.2. Body weight measurement
The variation in the body weights of all the animals subjected to
different treatments are shown in Table 1. Body weights were
measured at the beginning of treatment period and then were
recorded at the 2nd, 4th and 8th week. The body weights of the
animals of all the groups were found to increase progressively till
the end of eighth week. At the second week, no weight change was
observed in the OVX group when compared to the control group. At
the 4th (p < 0.05) and 8th (p < 0.01) week, themean body weight of
the animals in the ovariectomized group was signiﬁcantly higher in
comparison to the control animals. Zinc supplementation to the
OVX group showed increased body weight in comparison to the
control at the 2nd and 4th week, and at the 8th week mean body
weight of the animals was almost comparable to that of the control
group. The whole data is also summarized as body weight gain
(Table 2) for all the treatment groups.
3.3. Calcium content in bone tissue
Mean values of calcium concentration in both femur (p < 0.001)
and tibia (p < 0.001) were found to be signiﬁcantly reduced in theTable 1
Body weight of all the four groups at speciﬁc time intervals after surgery.
Groups Initial body weight (g) Body weight (g) after 2nd week
Control 130 ± 7 150 ± 8
Zinc 126 ± 5 149 ± 9
OVX 130 ± 7 155 ± 17
OVX þ zinc 130 ± 11 165 ± 12a
Each value is the mean ± SD (n ¼ 6).Values with a superscript are signiﬁcantly different
p < 0.05; e, p, <0.01; f, p < 0.001).ovariectomized group when compared to the normal control. Fe-
mur (p < 0.001) and tibia (p < 0.001) calcium concentrations were
enhanced in the OVX þ Zinc group and were restored to normal in
the case of femur bone. However, the tibia calcium levels upon zinc
supplementation to the OVX animals were not fully recovered
(p < 0.05) when compared to the normal control animals. Zinc
treatment alone to the control animals also showed increased
calcium levels in both the bone tissues and the increase was sig-
niﬁcant (p < 0.05) in the case of tibia.
3.4. Scanning electron microscopy of the trabecular region of bone
(both femur and tibia) tissue
Figs. 1 and 2 show the scanning electron microscopic images of
the trabecular portion of the femur and tibia endosteal region
respectively in different groups. As seen in Figs. 1 and 2 at a
magniﬁcation of 500, the femur and tibia bone of control animals
consisted of dense and well organized trabecular bone tissue. No
resorbed areas were identiﬁed in both the bones of the control
group. Micrographs of both the bones of ovariectomized group had
resorbed trabecular region. The connectivity of trabeculae is lost
following ovariectomy. The connectivity is more disrupted in the
case of tibia when compared to the femur group. Zinc supplemen-
tation to the control animals showed similar well arranged pattern
of the trabeculae as compared to the control. Administration of the
zinc to the OVX rats markedly reduces bone loss as is evident from
the micrographs showing dense network of trabeculae.
3.5. Hematoxylin and eosin staining of the trabecular region
H and E stained sections of the trabecular portion of the rat
femur bone at the lower magniﬁcation (5), revealed normal
trabecular architecture with the preservation of trabecular plate
and interconnectivity between trabeculae. Bone marrow cells were
seen in the spaces between the trabeculae (Fig. 3). However, as can
be seen from the micrograph of the OVX group, there was deteri-
oration and the thinning of the trabecular bone structure accom-
panied by the increase in the bone marrow. In addition, there was
widening of the spaces between the trabeculae as a result of
trabecular bone loss. Zinc supplementation to the OVX animals
resulted in thickening of the trabecular network making it dense as
that of the control bone (Table 4). Zinc supplementation to the
normal control animals maintained the connectivity of the
trabeculae, similar to that of the control bone.
3.6. Bone marrow cells (adiposity)
The ovariectomized group exhibited a signiﬁcant elevation in
the number of adipocytes as compared to the control group. Also, it
can be observed that ovariectomy leads to the formation of large
sized adipocytes (Fig. 4). Zinc supplementation to the OVX animals
down regulated the adipocyte number. However, the adipocyte
number remains almost similar to that of the control group when
zinc was supplementation alone to the control animal.Body weight (g) after 4th week Body weight (g) after 8th week
177 ± 8 217 ± 9
176 ± 8 215 ± 7
192 ± 16a 239 ± 19b
202 ± 14c 245 ± 15
from the control group (a, p < 0.05; b, p < 0.01; c, p < 0.001) or from Ovx group (d,
Table 2
Percentage body weight gain during the treatment period of all the four groups at speciﬁc time intervals after surgery.
Groups Body weight gain after 2nd week Body weight gain after 4th week Body weight gain after 8th week
Control 15 18 23
Zinc 18 18 22
OVX 19 24 24
OVX þ Zinc 27 22 21
Table 3
Effect of OVX and zinc supplementation on the calcium concentrations of femur and
tibia tissue.
Groups Femur calcium (mg/g of tissue) Tibia calcium (mg/g of tissue)
Control 204 ± 14 191 ± 6
Zinc 216 ± 16 201±7a
Ovx 157±5c 153±8c
Ovx þ Zinc 194 ± 10f 177±7f,a
Each value is the mean ± SD (n ¼ 6).Values with a superscript are signiﬁcantly
different from the control group (a, p < 0.05; b, p < 0.01; c, p < 0.001) or from Ovx
group (d, p < 0.05; e, p, <0.01; f, p < 0.001).
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4.1. Body weight gain
Body weights of the animals of all the groups were found to
increase progressively till the termination of the treatment period
(Tables 1 and 2). However, the percentage body weight gain
calculated was found to be consistently higher in the ovariecto-
mized group in comparison to the rest of the groups. This increase
in the bodyweight following ovariectomy could be attributed to the
excessive intake of food known as hyperphagia. Our results areFig. 1. Electron micrographs of the trabecular region of the femur (endosteal surface) at a m
showing densely formed trabecular arrangement; OVX group showing loss of trabecular
resorbed areas.consistent with the earlier reports suggesting that ovariectomy
increases food consumption and body mass [21,22]. Estradiol efﬁ-
ciently initiates a negative-feedback satiation signal and also
thought to exert inhibitory effects on feeding by augmenting
glucagon-mediated satiety signalling [23e25]. Also, the complex
interaction between estrogen and leptin levels in the central ner-
vous system and peripheral tissues also functions to control food
intake, body weight, and adiposity [26,27]. Therefore, reduction in
the estrogen levels as a consequence of post menopausal condition
would cause inhibition of the satiety signals and thus, leads to
excessive food intake, increase in the body weight and also the
adiposity.
4.2. Mechanism of zinc on bone resorption
Following ovariectomy, to conﬁrm the efﬁcacy of surgery pro-
tocol, the estradiol levels were evaluated. For this, the estradiol
levels have been checked using competitive binding assay shown in
our previous paper [17]. The results showed signiﬁcant decrease in
the estradiol levels following ovariectomy which gives the conﬁr-
mation of the success of the surgery protocol. At a molecular level,
the decline in the estradiol levels after ovariectomy might upre-
gulate the production of several cytokines, differentiation andagniﬁcation (500) of the control group showing well organized trabeculae; zinc group
connectivity; OVX þ Zinc group showing dense trabecular network. Arrows indicate
Fig. 2. Electron micrographs of the trabecular region of the tibia (endosteal surface) at a magniﬁcation (500) of the control group showing well organized trabecular network; Zinc
group showing similar pattern of trabeculae as that of the control; OVX group showing large areas of resorption and poorly organized trabeculae network; OVX þ Zinc group
showing well arranged trabeculae almost similar to that of control. Arrows indicate resorbed areas in the bone tissue. The resorbed areas in the trabecular region of ovariectomized
bone.
Fig. 3. H and E stained light micrographs of the femur collagenous trabecular region of Control; Zinc; OVX and OVX þ Zinc group. Arrows indicate trabeculae.
P. Bhardwaj et al. / Journal of Nutrition & Intermediary Metabolism 3 (2016) 33e40 37maturation of osteoclast, and ﬁnally protection of osteoclast against
apoptosis. Also, declined estogen levels will causemore secretion of
RANKL from the osteoblast cells instead of osteoprotegrin protein.
OPG is a decoy receptor which binds to the RANKL and prevents it
from activating RANK. Thus, with estrogen loss after surgicalremoval of ovaries, the osteoprotegrin levels decline, leaving
RANKL to bind to RANK and allowing differentiation of osteoclasts.
Osteoclasts will then develop rufﬂed border, get attached to the
bone surface and cause bone resorption [28e31].
Zinc supplementation to the ovariectomized animals caused
Table 4
Quantitative analysis of light micrographs of the trabecular region for
all the treatment groups.
Groups Trabecular thickness (mm)
Control 207 ± 21
Zinc 225 ± 19
OVX 124 ± 14c
OVX þ Zinc 175 ± 19f
Each value is the mean ± SD (n ¼ 6).Values with a superscript are
signiﬁcantly different from the control group (a, p < 0.05; b, p < 0.01; c,
p < 0.001) or from Ovx group (d, p < 0.05; e, p, <0.01; f, p < 0.001).
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secretion of estrogen from glands other than ovary like suprarenal
glands and adipose tissues. Further studies need to be carried out to
ﬁnd out the exact mechanism as to how the zinc stimulates es-
trogen secretion from the other glands.
Our previous study showed that Zinc directly improves the
antioxidant defense system of bone and indirectly decreases
oxidative stress by recovering estrogen levels. It has also been
shown in the study that there was zinc loss from the bone tissue in
the case of ovariectomized animals as found from the lowered zinc
concentrations in the bone tissue as well as serum [17] that gets
improved when zinc was supplemented externally to the animals
in drinking water daily. Enhanced bone resorption might cause
changes in the mineral content of the bone of which the most
important one is the calcium. Calcium concentrations in the femur
and tibia tissue were found to be signiﬁcantly reduced following
ovariectomy and improved upon zinc supplementation (Table 3).
The improvement in the calcium concentration directly reﬂects the
mineral portion of the bone tissue suggesting a plausible role of
zincon bone metabolism. It has also been observed from the pre-
vious data that in the case of ovariectomy, zinc loss occurs as a
result of enhanced bone resorption. When zinc was given to the
OVX animals, improvement in the zinc and copper levels of boneFig. 4. Adipocytes in the bone marrow section (shown by arrow) in thtissue causes increased osteoblastic activity [17] which further in-
duces mineralization and cellular protein synthesis.4.3. Micro architecture of bone
Microarchitecture of bone can be a determinant of bone fragility
independent of bone density [32]. Deterioration of the bone
microstructure as a result of any pathological disorder, will cause
substantial decrease in the bone strength and hence bone quality.
To identify the structural changes accompanying estrogen
deﬁciency-induced bone loss and the dietary effects on bone
metabolism, we have examined the changes in cancellous bone
microstructure using light microscopy and scanning electron mi-
croscopy in an ovariectomized osteopenic rat model. Increase in the
number of resorbed areas in the OVX group could be due to the
increased osteoclastic activity as indicated by increased TRAP-5b
levels [17]. Increased number of resorbed areas in the OVX group
is further substantiated by the decreased estrogen levels and
increased oxidative stress observed in our previous study. Bone
resorption following ovariectomy leads to dissolution of mineral
component present in the bone and thus causing fragmentation of
collagen matrix.
Trabecular bone consists of rod or plate like structures known as
trabeculae. Inter trabecular spaces are occupied by the bone
marrow cells. Both the cortical and trabecular bone tissue have the
similar functions but they differ in the geometry and arrangement.
Furthermore, following ovariectomy, resorbed trabecular
(Figs.1e3) regions were observed. Thereweremuch larger portions
of the endocortical surface lacking trabecular connections in the
OVX animals. This is due to the enhanced bone resorption following
ovariectomy. Zinc supplementation to the control animals showed
similar well arranged pattern of the trabeculae as compared to the
control. Administration of the zinc to the OVX rats markedly re-
duces bone loss as can be evident from the micrographs, showing
dense network of trabeculae.e Control, Zinc, OVX and OVX þ Zinc supplemented group (20).
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In the present work, adipose tissue content of the bone marrow
of the bones was found to increase following ovariectomy (Fig. 4).
This substantiates previous observations in the postmenopausal
women [33] and the OVX rats [34]. An increased adipose tissue
accumulation in the bone marrow has also been reported in asso-
ciation with age-related bone loss [35].
Osteopenic condition leads to the differentiation of adipocytes
at the expense of osteogenic cells. Increase in the adipocytes can
also be linked to an increased bone resorption. It has been reported
earlier by Benayahu et al. [36] that adipocytes have the potential to
stimulate osteoclast differentiation and, also secrete cytokines such
as tumour necrosis factor-alpha (TNFea) and interleukin (IL-6). So
from this, we can say that the increased adipocytes as observed in
the OVX condition might have increased the levels of various cy-
tokines which are required for the proliferation of osteoclast cells.
The increase in the osteoclast cells following ovariectomy has been
observed in our study as reported in the previous paper [17].
Zinc supplementation to the OVX animals decreased the num-
ber of adipocytes cells thereby suggesting the role of zinc in the
differentiation of bone marrow cells into osteogenic cells rather
than the adipocytes. Zinc ion may protect bone by decreasing
adipocyte formation, which may indirectly promote osteoblast
proliferation, mineral and bone formation, and also inhibiting
osteoclast formation, activation and bone resorption [37].
Thereby summarizing the above mentioned outcomes, we can
state that concomitance between increased bone marrow adipose
cells number and osteoclasts activity, with reduced bone trabeculae
of the estrogen deﬁcient rats may suggest a role for adipose cells in
ovariectomy induced bone loss. Zinc supplementation following
ovariectomy has been shown to regulate the number of adipocytes,
enhances bone calcium concentration and thus may help in
normalizing the structure deﬁcits to a greater extent. The
improvement in the micro architecture could be due to the
augmentation in the collagen synthesis as well as mineralization.
Zinc has been shown to cause differentiation of osteoblasts from
immature osteoblasts. Zinc directly activates aminoacyl-tRNA
synthetase in osteoblast cells and stimulates collagen synthesis.
This will cause the deposition of extracellular matrix which would
later on mineralize [38]. This shows that zinc is playing a very
important role in the bone mineral metabolism and hence exerts
bone protecting effect when supplemented in postmenopausal
condition.
5. Conclusion
Zinc is an important constituent of bone tissue and may
certainly associates with the bone micro architecture. From this
study, we conﬁrm that zinc supplementation if given at early stages
of bone loss will prevent the bone tissue deterioration.
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